DaVita Profit Margin 2010-2024 | DVA

Current and historical gross margin, operating margin and net profit margin for DaVita (DVA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. DaVita net profit margin as of December 31, 2024 is 7.31%.
DaVita Annual Profit Margins
DaVita Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.882B $12.816B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.823B 19.53
Encompass Health (EHC) United States $11.724B 24.85
Chemed (CHE) United States $8.428B 26.49
Option Care Health (OPCH) United States $5.373B 23.95
Elanco Animal Health (ELAN) United States $4.791B 10.60
RadNet (RDNT) United States $3.985B 84.33
Amedisys (AMED) United States $3.159B 21.25
LifeStance Health (LFST) United States $2.574B 0.00
Addus HomeCare (ADUS) United States $1.920B 21.08
Astrana Health (ASTH) United States $1.816B 36.39
U.S Physical Therapy (USPH) United States $1.097B 28.00
Pennant (PNTG) United States $0.928B 37.14
Aveanna Healthcare Holdings (AVAH) United States $0.925B 0.00
Atai Life Sciences (ATAI) Germany $0.294B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00